These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 35178565)

  • 21. Antimicrobial Use Fell Substantially in Japan in 2020-The COVID-19 Pandemic May Have Played a Role.
    Ono A; Koizumi R; Tsuzuki S; Asai Y; Ishikane M; Kusama Y; Ohmagari N
    Int J Infect Dis; 2022 Jun; 119():13-17. PubMed ID: 35306203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic.
    Rodríguez-Baño J; Rossolini GM; Schultsz C; Tacconelli E; Murthy S; Ohmagari N; Holmes A; Bachmann T; Goossens H; Canton R; Roberts AP; Henriques-Normark B; Clancy CJ; Huttner B; Fagerstedt P; Lahiri S; Kaushic C; Hoffman SJ; Warren M; Zoubiane G; Essack S; Laxminarayan R; Plant L
    J Glob Antimicrob Resist; 2021 Jun; 25():5-7. PubMed ID: 33662647
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The global governance of antimicrobial resistance: a cross-country study of alignment between the global action plan and national action plans.
    Munkholm L; Rubin O
    Global Health; 2020 Nov; 16(1):109. PubMed ID: 33176810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial use and antimicrobial resistance in Enterobacterales and Enterococcus faecium: a time series analysis.
    O'Riordan F; Shiely F; Byrne S; O'Brien D; Ronayne A; Fleming A
    J Hosp Infect; 2022 Feb; 120():57-64. PubMed ID: 34780809
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cross-sectional study of antimicrobial use among self-medicating COVID-19 cases in Nyeri County, Kenya.
    Kimathi G; Kiarie J; Njarambah L; Onditi J; Ojakaa D
    Antimicrob Resist Infect Control; 2022 Aug; 11(1):111. PubMed ID: 36042483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mapping global trends in vaccine sales before and during the first wave of the COVID-19 pandemic: a cross-sectional time-series analysis.
    Zeitouny S; Suda KJ; Mitsantisuk K; Law MR; Tadrous M
    BMJ Glob Health; 2021 Dec; 6(12):. PubMed ID: 34857523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of the COVID-19 pandemic on hospital antimicrobial consumption in Croatia.
    Vlahović-Palčevski V; Rubinić I; Payerl Pal M
    J Antimicrob Chemother; 2022 Sep; 77(10):2713-2717. PubMed ID: 35869875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future.
    Ohashi T; Nagashima M; Kawai N; Ohmagari N; Tateda K
    Expert Rev Anti Infect Ther; 2022 Dec; 20(12):1603-1614. PubMed ID: 36368311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Systematic Review of Antimicrobial Resistance During the COVID-19 Pandemic.
    Burnside JSW; Buchthal OV; Patil U
    Hawaii J Health Soc Welf; 2023 Aug; 82(8):188-193. PubMed ID: 37559691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A comparative assessment of action plans on antimicrobial resistance from OECD and G20 countries using natural language processing.
    Özçelik EA; Doucet C; Kang H; Levy N; Feldhaus I; Hashiguchi TCO; Lerouge A; Cecchini M
    Health Policy; 2022 Jun; 126(6):522-533. PubMed ID: 35379524
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Change in use of pediatric oral antibiotics in Japan, pre- and post-implementation of an antimicrobial resistance action plan.
    Iwamoto N; Morisaki N; Uda K; Kasai M; Kodama EN; Ohmagari N; Miyairi I
    Pediatr Int; 2022 Jan; 64(1):e15197. PubMed ID: 35770781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. It is time to define an organizational model for the prevention and management of infections along the surgical pathway: a worldwide cross-sectional survey.
    Sartelli M; Labricciosa FM; Coccolini F; Coimbra R; Abu-Zidan FM; Ansaloni L; Al-Hasan MN; Ansari S; Barie PS; Caínzos MA; Ceresoli M; Chiarugi M; Claridge JA; Cicuttin E; Dellinger EP; Fry DE; Guirao X; Hardcastle TC; Hecker A; Leppäniemi AK; Litvin A; Marwah S; Maseda E; Mazuski JE; Memish ZA; Kirkpatrick AW; Pagani L; Podda M; Rasa HK; Sakakushev BE; Sawyer RG; Tumietto F; Xiao Y; Aboubreeg WF; Adamou H; Akhmeteli L; Akin E; Alberio MG; Alconchel F; Magagi IA; Araúz AB; Argenio G; Atanasov BC; Atici SD; Awad SS; Baili E; Bains L; Bala M; Baraket O; Baral S; Belskii VA; Benboubker M; Ben-Ishay O; Bordoni P; Boumédiène A; Brisinda G; Cavazzuti L; Chandy SJ; Chiarello MM; Cillara N; Clarizia G; Cocuz ME; Cocuz IG; Conti L; Coppola R; Cui Y; Czepiel J; D'Acapito F; Damaskos D; Das K; De Simone B; Delibegovic S; Demetrashvili Z; Detanac DS; Dhingra S; Di Bella S; Dimitrov EN; Dogjani A; D'Oria M; Dumitru IM; Elmangory MM; Enciu O; Fantoni M; Filipescu D; Fleres F; Foghetti D; Fransvea P; Gachabayov M; Galeiras R; Gattuso G; Ghannam WM; Ghisetti V; Giraudo G; Gonfa KB; Gonullu E; Hamad YTEY; Hecker M; Isik A; Ismail N; Ismail A; Jain SA; Kanj SS; Kapoor G; Karaiskos I; Kavalakat AJ; Kenig J; Khamis F; Khokha V; Kiguba R; Kim JI; Kobe Y; Kok KYY; Kovacevic BM; Kryvoruchko IA; Kuriyama A; Landaluce-Olavarria A; Lasithiotakis K; Lohsiriwat V; Lostoridis E; Luppi D; Vega GMM; Maegele M; Marinis A; Martines G; Martínez-Pérez A; Massalou D; Mesina C; Metan G; Miranda-Novales MG; Mishra SK; Mohamed MIH; Mohamedahmed AYY; Mora-Guzmán I; Mulita F; Musina AM; Navsaria PH; Negoi I; Nita GE; O'Connor DB; Ordoñez CA; Pantalone D; Panyko A; Papadopoulos A; Pararas N; Pata F; Patel T; Pellino G; Perra T; Perrone G; Pesce A; Pintar T; Popivanov GI; Porcu A; Quiodettis MA; Rahim R; Mitul AR; Reichert M; Rems M; Campbell GYR; Rocha-Pereira N; Rodrigues G; Villamil GER; Rossi S; Sall I; Kafil HS; Sasia D; Seni J; Seretis C; Serradilla-Martín M; Shelat VG; Siribumrungwong B; Slavchev M; Solaini L; Tan BK; Tarasconi A; Tartaglia D; Toma EA; Tomadze G; Toro A; Tovani-Palone MR; van Goor H; Vasilescu A; Vereczkei A; Veroux M; Weckmann SA; Widmer LW; Yahya A; Zachariah SK; Zakaria AD; Zubareva N; Zuidema WP; Di Carlo I; Cortese F; Baiocchi GL; Maier RV; Catena F
    World J Emerg Surg; 2022 Mar; 17(1):17. PubMed ID: 35300731
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interrelationships between antimicrobial resistance, COVID-19, past, and future pandemics.
    Ukuhor HO
    J Infect Public Health; 2021 Jan; 14(1):53-60. PubMed ID: 33341485
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antimicrobial stewardship program during the COVID-19 pandemic].
    Jorge L; Lauricella MC; Klajn D; Molina AM; Del Valle S; Rodriguez VM
    Medicina (B Aires); 2022; 82(5):641-646. PubMed ID: 36220019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antimicrobial consumption in patients with COVID-19: a systematic review and meta-analysis.
    Khan S; Hasan SS; Bond SE; Conway BR; Aldeyab MA
    Expert Rev Anti Infect Ther; 2022 May; 20(5):749-772. PubMed ID: 34895002
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship?
    Walia K; Mendelson M; Kang G; Venkatasubramanian R; Sinha R; Vijay S; Veeraraghavan B; Basnyat B; Rodrigues C; Bansal N; Ray P; Mathur P; Gopalakrishnan R; Ohri VC
    Lancet Infect Dis; 2023 Aug; 23(8):e301-e309. PubMed ID: 37290476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of COVID-19: implications for antimicrobial resistance in Africa.
    Iwu CJ; Jordan P; Jaja IF; Iwu CD; Wiysonge CS
    Pan Afr Med J; 2020; 35(Suppl 2):119. PubMed ID: 33282074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use.
    Shrestha P; Cooper BS; Coast J; Oppong R; Do Thi Thuy N; Phodha T; Celhay O; Guerin PJ; Wertheim H; Lubell Y
    Antimicrob Resist Infect Control; 2018; 7():98. PubMed ID: 30116525
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic consumption in hospitals during COVID-19 pandemic: a comparative study.
    Hussein RR; Rabie ASI; Bin Shaman M; Shaaban AH; Fahmy AM; Sofy MR; Lattyak EA; Abuelhana A; Naguib IA; Ashour AM; Aldeyab MA
    J Infect Dev Ctries; 2022 Nov; 16(11):1679-1686. PubMed ID: 36449638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The approach of World Health Organization to articulate the role and assure impact of vaccines against antimicrobial resistance.
    Frost I; Balachandran A; Paulin-Deschenaux S; Sati H; Hasso-Agopsowicz M
    Hum Vaccin Immunother; 2022 Nov; 18(6):2145069. PubMed ID: 36420615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.